Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma (pages 1685–1692)
Eric T. Shinohara, Adriana Gonzalez, Pierre P. Massion, Heidi Chen, Ming Li, Andrea S. Freyer, Sandra J. Olson, Jeremiah J. Andersen, Yu Shyr, David P. Carbone, David H. Johnson, Dennis E. Hallahan and Bo Lu
Version of Record online: 1 MAR 2005 | DOI: 10.1002/cncr.20951
The nuclear localization of survival may play a vital role in predicting recurrence and overall survival in patients with lung carcinoma. In this study, the authors investigated whether using survivin as a prognostic marker may allow physicians to tailor radiation and chemotherapy better for specific patients.